Sponsored Content
Recent Posts
- Treatment switches in FAP are common, reasons numerous: Study
- Phase 3 trial is tracking use of acoramidis to block ATTR onset
- I wish my country could benefit from gains in amyloidosis treatment
- Long-term Amvuttra treatment safe, pooled trial analysis shows
- Gene therapy nex-z lowers FAP protein levels for 3 years